Watchlist
TSEM · Tower Semiconductor Ltd.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 10 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Current thesis
Picks-and-shovels photonics foundry where the demand chain keeps beating and the equity has only just begun to follow: the line closed $206.81 on 2026-09-02, reclaiming the $200 shelf, hours before Broadcom guided Q4 AI semiconductor revenue to $21.7B and framed fiscal-2027 AI revenue at approximately $115B. The demand-layer narrative is accelerating while equity confirmation is one session old, with no company-dated number before the ~2026-11-04 Q3 print.
Kill line
A weekly close below $195, back beneath the 2026-09-01 close of $199.06 that the 2026-09-02 close of $206.81 reclaimed, marks the $200 shelf failing rather than repairing. Secondary: the 2026-09-10 Benchmark-StoneX appearance passing with no reiteration of the $3.6B revenue / $1.2B net-profit 2028 model published 2026-07-14.
Pick status
Open commitment catalyst 1d agoscored if the kill line above fires How this is scored →Latest analysis and events for TSEM —
As of 3 September 2026, the latest FrontierPicks analysis for Tower Semiconductor Ltd. (TSEM): 22 April 2026: Theme registry narrowed to ai-chip-infra-memory only; silicon-photonics and specialty-foundry themes dropped from emergent registry — thematic umbrella is thinner this week, reduces thematic bid.
Kill line: A weekly close below $195, back beneath the 2026-09-01 close of $199.06 that the 2026-09-02 close of $206.81 reclaimed, marks the $200 shelf failing rather than repairing. Secondary: the 2026-09-10 Benchmark-StoneX appearance passing with no reiteration of the $3.6B revenue / $1.2B net-profit 2028 model published 2026-07-14.
Most recent dated event on file: — catalyst 1d ago.
Current Thesis
Tower fabricates silicon-photonics wafers and process IP one layer beneath the optical-module and custom-silicon vendors the market reprices first, and it books part of the 2027 order set as customer prepayments before the wafers ship. That frame has held since April. Through August it produced one repeating result: a dated positive event, then a lower close. The 2026-08-04 Q2 beat and raise, Bank of America's Buy initiation at $367 on 2026-08-07, Lumentum's beat on 2026-08-11, Marvell's Q2 FY2027 beat on 2026-08-27, and Stifel's Buy initiation at $270 reported 2026-09-02 all landed into a falling line.
Two dated items broke that run. Price closed $206.81 on 2026-09-02, up 3.9% from $199.06 the prior session and back through the $200 shelf it had lost, with RSI(14) at 28.4 against the 21.3 reading carried in the 2026-09-01 note. After that close, Broadcom reported Q3 FY2026 revenue of $29.6B (+86% YoY), non-GAAP diluted EPS of $3.32 and AI semiconductor revenue of $16.7B (+221% YoY, +54% QoQ), guided Q4 to approximately $34.8B including $21.7B of AI semiconductor revenue, and on the call framed fiscal-2027 AI revenue at approximately $115B and fiscal-2028 at approximately $230B, with CEO Hock Tan stating supply is secured for the 2027 figure and in line of sight for 2028.
Separate measured from inferred. Measured: the largest scheduled read on 2027 optical and custom-silicon demand accelerated rather than decelerated, and the specific bear observable this coverage had published for that date — Broadcom guiding data-centre revenue below consensus — did not occur. Inferred: a larger 2027 accelerator and networking build raises the odds that the January 2027 wafer-commitment checkpoint disclosed on 2026-05-13 lands with incremental prepayments rather than a renegotiation. That is a chain-level inference; Broadcom is not a disclosed Tower customer.
On where the story sits, the narrative is accelerating at the demand layer — Broadcom lifted the fiscal-2027 AI frame to approximately $115B on 2026-09-02, and two brokers initiated Tower inside four weeks (BofA 2026-08-07, Stifel reported 2026-09-02) — while the equity's own confirmation is a single session old and the next company-dated number, the Q3 print estimated ~2026-11-04, is roughly nine weeks out.
Bullish and bearish views on Tower Semiconductor Ltd.
The model's bull view on Tower Semiconductor Ltd. (TSEM), in brief: The last company print beat and has not been revised. The bear view: Five dated positives between 2026-08-04 and 2026-09-01 produced five lower closes. Both cases follow in full.
Bull Case
- The last company print beat and has not been revised. Q2 FY26 on 2026-08-04: revenue $460.079M against $454.680M consensus, adjusted EPS $0.88 against $0.76, and a Q3 guide of $494.000M–$546.000M whose floor clears the $490.016M street estimate.
- Margin moved with volume. Form 6-K filed 2026-08-17: H1 2026 revenue $873.710M (+19.6% YoY), gross margin 28.5% against 21.0% in H1 2025, net profit attributable $155.801M against $86.7M, shareholders' equity $3.071B.
- Part of 2027 is contracted and pre-paid. Disclosed 2026-05-13: $1.3B of contracted 2027 silicon-photonics revenue, $290M of customer prepayments for capacity reservation, more than 50 active SiPho customers, and further prepayments tied to a larger 2028 wafer commitment due January 2027.
- The demand backdrop those contracts were signed into got bigger. Broadcom's 2026-09-02 release and call: Q4 AI semiconductor revenue guided to $21.7B, fiscal-2026 AI revenue approximately $58B, fiscal-2027 approximately $115B, fiscal-2028 approximately $230B.
- The capacity build has a sovereign co-funder. The 2026-07-14 METI-backed announcement: approximately $3B of Tower investment net of $1B of Government of Japan grants, Arai repurposed for 300mm silicon photonics and advanced packaging with full readiness targeted late 2027, plus a new 300mm fab adjacent to Fab 7, and a 2028 model of approximately $3.6B revenue and $1.2B net profit.
- The named counterparty guided up. Marvell's 2026-08-27 Q2 FY2027 release: revenue $2.739B (+37% YoY), data centre $2.171B at 79% of total and +46% YoY, Q3 guided to $3.150B ±5%.
Bear Case
- Five dated positives between 2026-08-04 and 2026-09-01 produced five lower closes. One higher close on 2026-09-02 is a one-observation sample against that record and settles nothing.
- The Broadcom read is second-order. Tower's disclosed photonics counterparty is Marvell; the approximately $115B fiscal-2027 AI frame is a demand signal for the chain, not an order at Tower, and converts only through the January 2027 wafer commitment and the Q3/Q4 prints.
- The marginal target is drifting down. Stifel's $270 anchors beneath Wedbush's $300 Hold (2026-08-03), Benchmark's $335 (2026-05-14) and BofA's $367 (2026-08-07), against a 2026-09-02 close of $206.81.
- Cash against commitment. Cash and equivalents were $231.188M at 2026-06-30 against $342.953M of H1 capex and an approximately $3B Japan programme net of grants.
- Cash-flow quality is thinner than the headline. $282.582M of the $686.934M H1 operating cash flow was customer advances, which do not repeat without new capacity reservations.
- The 2028 framework has been restated and never bridged. $2.8B on 2026-05-13, $3.6B on 2026-07-14, with no public reconciliation of the two.
- Insider flow runs one way. The CEO sold 66,964 ordinary shares on the TASE in July 2026 across ten transactions under an instruction pre-arranged 2026-03-12, at weighted averages spanning $210.33–$211.27, holding 764,388 directly after; no insider buying has been reported since.
Setup & Price Structure
The reference close on 2026-09-02 is $206.81, 34.7% below the $316.85 52-week high, with a three-month price change of -20.9% and RSI(14) at 28.4. The recent sequence: a weekly close of $208.01 on 2026-08-28, $205.05 on 2026-08-31, $199.06 on 2026-09-01, then $206.81 on 2026-09-02. The $200 shelf was lost on one session and reclaimed on the next, and the week ending 2026-09-04 requires a Friday close above $208.01 to register a higher weekly close than the prior week.
Immediately overhead sits the $210.33–$211.27 band where the CEO's July sales printed; price has traded beneath it since the 2026-08-28 weekly close cut through. Nothing in the structure has yet built a base above that band.
Positioning observables, stated as observables: RSI(14) at 28.4 sits below 30, which is not the reading of a crowded long; sell-side coverage expanded twice in four weeks while price fell 20.9% over three months, so analyst participation widened without the bid widening; the seven-analyst panel on stockanalysis.com averaged $321.32 on 2026-09-02 against a $206.81 close, a gap that has been growing rather than closing; no company earnings date falls inside 30 days; a 2x leveraged single-stock ETF (Tradr TSEU, Cboe-listed) has traded since 2026-07-01, adding daily-reset amplification to a US line thinner than large-cap foundry peers; and the only reported insider transactions of 2026 are sales.
Catalyst Calendar (next 30 days)
Just outside the window, both dated: 2026-10-06, Marvell Investor Day in New York City (announced 2026-08-03), where multi-year AI-networking and custom-silicon targets from Tower's named photonics counterparty frame 2027–2028 wafer demand; and ~2026-11-04 (est.), Tower's Q3 FY26 results, the first test of the $494.000M–$546.000M guide issued 2026-08-04.
Elapsed catalysts
- 2026-09-10 — Benchmark-StoneX 13th Annual Tech, Media and Telecom Conference, New York Athletic Club (participation disclosed 2026-08-12). The only scheduled company appearance inside the window, and the first since the $200 break and the Broadcom print; the natural occasion to reiterate or drop the $3.6B revenue / $1.2B net-profit 2028 model published 2026-07-14, and to address the unbridged $2.8B figure from 2026-05-13. (passed 1d ago)
- 2026-09-03 onward — the first sessions of trading after Broadcom's 2026-09-02 report. Unscheduled, but the cleanest observation available of whether a chain-level demand beat now converts into a bid for the foundry layer, after five prior attempts did not. (passed 8d ago)
What Would Change Our Mind
The repair breaks if the 2026-09-02 reclaim of $200 fails to hold into a completed week: a weekly close below $195 would put price beneath the 2026-09-01 close of $199.06 that the reclaim was measured against, and would mean the Broadcom print joined the 2026-08-04, 2026-08-07, 2026-08-11, 2026-08-27 and 2026-09-01 events as good news the tape declined to price.
The secondary conditions are datable. The 2026-09-10 conference passing with no public reiteration of the $3.6B/$1.2B 2028 model would leave the sell-side targets anchored to a figure management last stated on 2026-07-14 and has never reconciled with the earlier $2.8B. A Q3 print inside the guided range but with gross-profit growth below revenue growth would show incremental silicon-photonics capacity arriving at a margin below the 28.5% H1 level. An equity or convertible issuance, or a raised capex guide without matching new customer prepayments, would answer the Japan funding question the wrong way against $231.188M of cash at 2026-06-30.
In the other direction, a Friday close above $208.01 followed by acceptance above the $210.33–$211.27 July insider band would be the first structural evidence that the demand-chain data is reaching the equity, and a January 2027 checkpoint that produces incremental prepayments would convert the Broadcom fiscal-2027 frame into Tower's own order book.
Correlation Notes
TSEM does not track the semiconductor cohort one-for-one; it amplifies it. Recent sessions: approximately -10% against SOXX's -6% on 2026-08-18, +6.67% against +1.05% on 2026-08-03, -7.46% against -5.33% on 2026-07-29. The 2x leveraged single-stock product listed 2026-07-01 mechanically adds to that amplitude in both directions.
The dual TASE listing trades Sunday–Thursday and frequently sets the US open, so the first US print after a weekend or a US holiday often reflects an Israeli session the US tape has not yet seen.
The relevant read-through chain runs Broadcom and Marvell (custom silicon, co-packaged optics, AI networking) → optical module and laser vendors (Lumentum) → photonics wafer capacity. Tower sits at the far end, which is why the 2026-09-02 Broadcom guide matters to the thesis and why it does not appear in Tower's own revenue for several quarters. Within the specialty-foundry cohort, UMC and GlobalFoundries have moved with TSEM on hyperscaler capex headlines, which is the mechanism by which a company-specific beat gets overridden, as on 2026-08-18.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-04-22: Theme registry narrowed to ai-chip-infra-memory only; silicon-photonics and specialty-foundry themes dropped from emergent registry — thematic umbrella is thinner this week, reduces thematic bid.
- Dual-listed on the Tel Aviv Stock Exchange (Sunday-Thursday), which frequently sets the US open; the US line is thinner than large-cap foundry peers.
- Insider trades are often executed on the TASE and reported in ILS at a conversion rate stated inside the filing, so Form 4 dollar figures depend on that disclosed rate.
- Aggregators disagree on Q2 consensus revenue ($454.680M vs $463.774M against $460.079M reported), so beat/miss framing varies by source.
- Analyst-target panels disagree materially: stockanalysis.com showed a $321.32 average across seven analysts on 2026-09-02, while other summary pages have shown far lower averages.
- A 2x leveraged single-stock ETF (Tradr TSEU, Cboe-listed) has traded since 2026-07-01, adding daily-reset amplification in both directions.
- Tower restated its 2028 revenue framework twice in 2026 - $2.8B on 2026-05-13, $3.6B on 2026-07-14 - and has not publicly bridged the two figures.
Related · shared themes
UMC
United Microelectronic Corp.
Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2 print is now the binary that decides whether the leg resumes or the re-rate unwinds.
NVCT
Nuvectis Pharma, Inc.
Nuvectis re-rated on the 2026-06-22 Haisco ex-China in-license and the 2026-07-23 China approval of oral Factor B inhibitor ciprocopan; Nothing binary lands inside 30 days — only conference slots on 09-11 and 09-14, against RSI 72.3 and a 160% three-month advance.
AEHR
Aehr Test Systems
Wafer-level burn-in toll on AI silicon: fiscal 2027 guided $130.0–150.0M against $50.0M in fiscal 2026, unamended on the wire as of 2026-09-03. The unwind paused — $80.24 on 2026-09-02 against $76.59 the prior session, RSI(14) 27.3 from 22.9, still 44.9% under the 52-week high — leaving a saturated narrative with no company-dated catalyst before the 2026-09-10 Lake Street venue and an October print vendor calendars date differently.
AEIS
Advanced Energy Industries, Inc.
Datacenter-power picks-and-shovels re-rating is now fully mainstream — Morgan Stanley initiated Overweight $421 (07-22) atop Wells $465 and Susquehanna $535 — yet the stock fell 12.65% on 07-02 and is sitting on its 200-day while analyst targets keep climbing. Sell-side saturation against a broken tape; the confirmed 2026-08-03 Q2 print is the binary.
See also · stocks to watch